New treatments for acute humoral rejection of kidney allografts. - Wikidata - wikimedia - TriplyDB

New treatments for acute humoral rejection of kidney allografts.

New treatments for acute humoral rejection of kidney allografts.

http://www.wikidata.org/entity/Q36802609

about

Therapeutic apheresis in renal transplantation; current practices.Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.A case of desensitization, transplantation, and allograft dysfunction.Current progress in ABO-incompatible kidney transplantation Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection.Allogeneic islet transplantation.Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.Cell-mediated and humoral acute vascular rejection and graft loss: A registry study.The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection.Successful rescue of refractory acute antibody-mediated renal allograft rejection with splenectomy--a case report.Successful treatment of severe acute antibody-mediated rejection of renal allografts with bortezomib--a report of two pediatric cases.A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.

P2860

Q30458220-13618A60-7A41-4DF5-A978-CE66F5176DEE Q34026630-ECC8D3B3-C0D4-4DD9-9A86-BFBCBC737603 Q34927206-3EE15A36-0F29-4C5C-9E2C-9D3285DABBA6 Q35607565-09481592-8479-415B-8303-BA4898A732D8 Q36063312-32156B2C-A7F6-4296-AEBF-738076DBB9AD Q36171175-28DD905D-37FF-4141-B378-B4A4474850A9 Q36227374-1035EEF7-2CAD-49F0-A7BF-AE5F7EC93D1C Q36981652-2A51E8CF-EE9F-4AD7-A8D2-9E0A88339FE3 Q37990988-A50FC80F-C188-4C3D-BB9F-9F2D7D49558C Q38977574-6E5FA3CF-2E56-4728-AE9D-CFB9F444CE1B Q39254100-3CB42E18-FBCA-4A1A-A3D0-A9EAB9096440 Q40321824-C6C3BD0C-483F-46BA-A52A-359FD0B10110 Q40958100-0F2BD7CD-7622-4CCC-BDD1-992CC23CE13E Q41791356-89176152-DED5-43ED-ADC8-230D9FF7AD58 Q47362322-3808D1A5-3564-48D9-AB09-6E3A5598C885

P2860

New treatments for acute humoral rejection of kidney allografts.

http://www.wikidata.org/entity/Q36802609

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

New treatments for acute humoral rejection of kidney allografts.

@ast

New treatments for acute humoral rejection of kidney allografts.

@en

type

label

New treatments for acute humoral rejection of kidney allografts.

@ast

New treatments for acute humoral rejection of kidney allografts.

@en

prefLabel

New treatments for acute humoral rejection of kidney allografts.

@ast

New treatments for acute humoral rejection of kidney allografts.

@en

P1433

Q36802609-902EED78-2B17-43A0-9F2A-B0CD5BA59C10

P1476

Q36802609-4F04EDDA-EADE-4BF6-A93A-60ECEE1B08FA

P2093

Q36802609-0DD0BF59-601C-4BB5-93CF-FBEC134BEB6C

Q36802609-29BC6E49-AD67-4EAD-A97B-91EE0E2C37E4

P2860

Q36802609-069DEEFC-FA32-46EC-90CE-E69BF169BF6E

Q36802609-14B0B664-573B-4B4C-AD0B-B3A566A2E3BA

Q36802609-18738DC5-20AD-4B76-8935-21B708EB6D96

Q36802609-18868700-4D6C-470C-87BB-3831FE8CE06A

Q36802609-1F39922E-90CC-4EEE-BADD-6979D85F5974

Q36802609-2023FE73-BB0F-4406-8F73-B4E7B8F8CD16

Q36802609-262A75A9-CA49-4DB8-8FAD-884CA90DD2F7

Q36802609-2D921202-EE57-46CF-811F-BCDCA77D5B14

Q36802609-2F61E410-7A93-4E78-8F70-2EB83DEF593B

Q36802609-3752012A-817A-4298-9DEB-56BD81C944CF

P304

Q36802609-FBBAD62A-A281-456C-B2CE-5890E25AA063

P31

Q36802609-E44BD8B9-4654-4412-8517-42969E7F6F2D

P356

Q36802609-5A2866BC-5211-483C-859B-AF3A143D06DC

P407

Q36802609-45DB0299-C99A-41AC-8DD8-7346E4F3E3B4

P433

Q36802609-75231669-41C3-4ED8-B90C-0B51903BFCA1

P478

Q36802609-AE8BC41E-0872-4803-85A0-12A7099E35E0

P577

Q36802609-50964B2C-41DE-4C8D-A426-D717BB1700D5

P698

Q36802609-F30BDBC0-B518-4CAC-ADCF-CAB05E9A35B2

P356

13543784.16.5.625

P1433

Expert Opinion on Investigational Drugs

P1476

New treatments for acute humoral rejection of kidney allografts.

@en

P2093

Jean-Pierre Venetz

http://www.w3.org/2001/XMLSchema#string

Manuel Pascual

http://www.w3.org/2001/XMLSchema#string

P2860

Rapamycin in transplantation: a review of the evidence.

B cell targeted therapies

Tacrolimus rescue therapy for renal allograft rejection--five-year experience

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols.

Humoral rejection of organ allografts.

Epratuzumab in the therapy of oncological and immunological diseases.

P304

625-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.5.625

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17461736

http://www.w3.org/2001/XMLSchema#string